Literature DB >> 29250168

Anti-angiogenic effect of Livistona chinensis seed extract in vitro and in vivo.

Zhiyun Cao1,2, Liangpu Zheng1,2, Jinyan Zhao1,2, Qunchuan Zhuang1,2, Zhenfeng Hong1, Wei Lin1,2.   

Abstract

The present study aimed to detect the impact of the ethanol extract of the Livistona chinensis seed (EELC) on angiogenesis in human umbilical vein endothelial cells (HUVECs). A chorioallantoic membrane (CAM) assay was used to detect the anti-angiogenic activity of EELC in vivo. In vitro, the effect of EELC on the proliferation, migration and angiogenesis of HUVECs was determined by an MTT assay, a wound healing assay and a tube formation assay, respectively. The vascular endothelial growth factor (VEGF)-A and VEGF receptor (VEGFR)-2 protein and mRNA level were measured with ELISA and reverse transcription-semi-quantitative polymerase chain reaction. It was observed that EELC significantly decreased the formation of new vessels in the CAM assay. EELC inhibited the proliferation and migration of HUVECs. The extent of tube formation by HUVECs was also reduced by EELC. In addition, EELC treatment reduced the level of VEGF-A and VEGFR-2 mRNA and protein. The results suggest that EELC inhibits tumor angiogenesis through inhibiting the proliferation and migration of HUVECs, and by downregulating VEGF and VEGFR.

Entities:  

Keywords:  angiogenesis; ethanol extract of Livistona chinensis seed; vascular endothelial growth factor

Year:  2017        PMID: 29250168      PMCID: PMC5727618          DOI: 10.3892/ol.2017.7075

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.

Authors:  Xu-Zheng Chen; Zhi-Yun Cao; Tuan-Sheng Chen; You-Quan Zhang; Zhi-Zhen Liu; Yin-Tao Su; Lian-Ming Liao; Jian Du
Journal:  Oncol Rep       Date:  2012-05-25       Impact factor: 3.906

3.  Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.

Authors:  Wen-Chuang Huang; Rae-Mann Hsu; Lang-Ming Chi; Yann-Lii Leu; Yu-Sun Chang; Jau-Song Yu
Journal:  Cancer Lett       Date:  2006-08-21       Impact factor: 8.679

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

6.  [Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect].

Authors:  Hui Wang; Ao Li; Xiao-Ping Dong; Xiao-Yu Xu
Journal:  Zhong Yao Cai       Date:  2008-05

7.  Livistona chinensis seeds inhibit hepatocellular carcinoma angiogenesis in vivo via suppression of the Notch pathway.

Authors:  Wei Lin; Jinyan Zhao; Zhiyun Cao; Qunchuan Zhuang; Liangpu Zheng; Jianwei Zeng; Zhenfeng Hong; Jun Peng
Journal:  Oncol Rep       Date:  2014-02-24       Impact factor: 3.906

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

Review 9.  Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

Authors:  Napoleone Ferrara
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

View more
  2 in total

1.  Protective effects of five compounds from Livistona chinensis R. Brown leaves against hypoxia/reoxygenation, H2O2, or adriamycin-induced injury in H9c2 cells.

Authors:  Shaoguang Li; Shaohong Luo; Hao Chen; Yanjie Zheng; Liqing Lin; Hong Yao; Xinhua Lin
Journal:  Drug Des Devel Ther       Date:  2019-05-08       Impact factor: 4.162

2.  Antioxidant, Anti-Inflammatory, and Antidiabetic Activities of Bioactive Compounds from the Fruits of Livistona chinensis Based on Network Pharmacology Prediction.

Authors:  Yuwei Wang; Jianxiu Zhai; Dan Yang; Na Han; Zhe Liu; Zhihui Liu; Sikai Li; Jun Yin
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.